Adc Therapeutics Sa Stock Buy Hold or Sell Recommendation
| ADCT Stock | USD 1.85 0.08 4.52% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding ADC Therapeutics SA is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell ADC Therapeutics SA given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for ADC Therapeutics SA, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out ADC Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as ADC and provide practical buy, sell, or hold advice based on investors' constraints. ADC Therapeutics SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
ADC |
Execute ADC Therapeutics Buy or Sell Advice
The ADC recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on ADC Therapeutics SA. Macroaxis does not own or have any residual interests in ADC Therapeutics SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute ADC Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
ADC Therapeutics Trading Alerts and Improvement Suggestions
| ADC Therapeutics had very high historical volatility over the last 90 days | |
| ADC Therapeutics may become a speculative penny stock | |
| ADC Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 69.56 M. Net Loss for the year was (240.05 M) with loss before overhead, payroll, taxes, and interest of (59.85 M). | |
| ADC Therapeutics SA currently holds about 376.78 M in cash with (118.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.9, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 63.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: ADC THERAPEUTICS SA -REDH Earnings Preview Recent ADCT Insider Trading, Hedge Fund Activity, and More - Nasdaq |
ADC Therapeutics Returns Distribution Density
The distribution of ADC Therapeutics' historical returns is an attempt to chart the uncertainty of ADC Therapeutics' future price movements. The chart of the probability distribution of ADC Therapeutics daily returns describes the distribution of returns around its average expected value. We use ADC Therapeutics SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of ADC Therapeutics returns is essential to provide solid investment advice for ADC Therapeutics.
| Mean Return | -0.52 | Value At Risk | -9.66 | Potential Upside | 8.78 | Standard Deviation | 7.05 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of ADC Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
ADC Stock Institutional Investors
The ADC Therapeutics' institutional investors refer to entities that pool money to purchase ADC Therapeutics' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Ubs Group Ag | 2024-12-31 | 884.5 K | Vantage Consulting Group Inc. | 2024-12-31 | 850.7 K | Blue Owl Capital Holdings Lp | 2024-12-31 | 733.6 K | Bnp Paribas Arbitrage, Sa | 2024-12-31 | 716.7 K | Vanguard Group Inc | 2024-12-31 | 644.6 K | Northern Trust Corp | 2024-12-31 | 476.2 K | Millennium Management Llc | 2024-12-31 | 411.1 K | Wellington Management Company Llp | 2024-12-31 | 253.3 K | Dafna Capital Management Llc | 2024-12-31 | 224.1 K | Redmile Group, Llc | 2024-12-31 | 15.7 M | Prosight Management, Lp | 2024-12-31 | 9.5 M |
ADC Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ADC Therapeutics or Communications Equipment sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ADC Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ADC stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.37 | |
β | Beta against Dow Jones | 1.42 | |
σ | Overall volatility | 5.30 | |
Ir | Information ratio | -0.06 |
ADC Therapeutics Volatility Alert
ADC Therapeutics SA is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure ADC Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact ADC Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.ADC Therapeutics Fundamentals Vs Peers
Comparing ADC Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ADC Therapeutics' direct or indirect competition across all of the common fundamentals between ADC Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as ADC Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ADC Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing ADC Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ADC Therapeutics to competition |
| Fundamentals | ADC Therapeutics | Peer Average |
| Return On Equity | -7.06 | -0.31 |
| Return On Asset | -0.21 | -0.14 |
| Profit Margin | (3.00) % | (1.27) % |
| Operating Margin | (1.93) % | (5.51) % |
| Current Valuation | 21.42 M | 16.62 B |
| Shares Outstanding | 96.69 M | 571.82 M |
| Shares Owned By Insiders | 20.64 % | 10.09 % |
| Shares Owned By Institutions | 63.17 % | 39.21 % |
| Number Of Shares Shorted | 5.3 M | 4.71 M |
| Price To Earning | 19.80 X | 28.72 X |
| Price To Book | 2.58 X | 9.51 X |
| Price To Sales | 2.53 X | 11.42 X |
| Revenue | 69.56 M | 9.43 B |
| Gross Profit | (59.85 M) | 27.38 B |
| EBITDA | (146.76 M) | 3.9 B |
| Net Income | (240.05 M) | 570.98 M |
| Cash And Equivalents | 376.78 M | 2.7 B |
| Cash Per Share | 4.90 X | 5.01 X |
| Total Debt | 124.38 M | 5.32 B |
| Debt To Equity | 2.75 % | 48.70 % |
| Current Ratio | 5.76 X | 2.16 X |
| Book Value Per Share | (1.78) X | 1.93 K |
| Cash Flow From Operations | (118.69 M) | 971.22 M |
| Short Ratio | 11.50 X | 4.00 X |
| Earnings Per Share | (2.39) X | 3.12 X |
| Price To Earnings To Growth | 0.74 X | 4.89 X |
| Target Price | 8.8 | |
| Number Of Employees | 273 | 18.84 K |
| Beta | 1.52 | -0.15 |
| Market Capitalization | 178.88 M | 19.03 B |
| Total Asset | 354.78 M | 29.47 B |
| Retained Earnings | (1.34 B) | 9.33 B |
| Working Capital | 268.62 M | 1.48 B |
Note: Discretionary transaction by Redmile Group, Llc of 1259822 shares of ADC Therapeutics at 3.25 subject to Rule 16b-3 [view details]
ADC Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ADC . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About ADC Therapeutics Buy or Sell Advice
When is the right time to buy or sell ADC Therapeutics SA? Buying financial instruments such as ADC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having ADC Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Global Macro ETFs Thematic Idea Now
Global Macro ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Global Macro ETFs theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Global Macro ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for ADC Stock Analysis
When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.